No study assessing the prognostic value of mTOR/p-mTOR in Western ESCC patients was identified but only one study reported by Boone et al. [38] analyzed the relationship between mTOR/p-mTOR expression and clinicopathological features of 105 ESCC patients from the Netherlands. The gene discussed is MTOR; the disease is esophageal squamous cell carcinoma.